IRIS Accounts Production v24.3.2.46 09231427 Board of Directors Board of Directors 1.12.23 30.11.24 30.11.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh092314272023-11-30092314272024-11-30092314272023-12-012024-11-30092314272022-11-30092314272022-12-012023-11-30092314272023-11-3009231427ns15:EnglandWales2023-12-012024-11-3009231427ns14:PoundSterling2023-12-012024-11-3009231427ns10:Director12023-12-012024-11-3009231427ns10:Director22023-12-012024-11-3009231427ns10:PrivateLimitedCompanyLtd2023-12-012024-11-3009231427ns10:SmallEntities2023-12-012024-11-3009231427ns10:AuditExempt-NoAccountantsReport2023-12-012024-11-3009231427ns10:SmallCompaniesRegimeForDirectorsReport2023-12-012024-11-3009231427ns10:SmallCompaniesRegimeForAccounts2023-12-012024-11-3009231427ns10:FullAccounts2023-12-012024-11-3009231427ns10:RegisteredOffice2023-12-012024-11-3009231427ns5:CurrentFinancialInstruments2024-11-3009231427ns5:CurrentFinancialInstruments2023-11-3009231427ns5:Non-currentFinancialInstruments2024-11-3009231427ns5:Non-currentFinancialInstruments2023-11-3009231427ns5:ShareCapital2024-11-3009231427ns5:ShareCapital2023-11-3009231427ns5:RetainedEarningsAccumulatedLosses2024-11-3009231427ns5:RetainedEarningsAccumulatedLosses2023-11-3009231427ns5:FurnitureFittings2023-12-012024-11-3009231427ns5:MotorVehicles2023-12-012024-11-3009231427ns5:ComputerEquipment2023-12-012024-11-3009231427ns5:FurnitureFittings2023-11-3009231427ns5:MotorVehicles2023-11-3009231427ns5:ComputerEquipment2023-11-3009231427ns5:FurnitureFittings2024-11-3009231427ns5:MotorVehicles2024-11-3009231427ns5:ComputerEquipment2024-11-3009231427ns5:FurnitureFittings2023-11-3009231427ns5:MotorVehicles2023-11-3009231427ns5:ComputerEquipment2023-11-3009231427ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2023-11-3009231427ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2023-12-012024-11-3009231427ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2024-11-3009231427ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2023-11-3009231427ns5:WithinOneYearns5:CurrentFinancialInstruments2024-11-3009231427ns5:WithinOneYearns5:CurrentFinancialInstruments2023-11-3009231427ns5:DeferredTaxation2023-11-3009231427ns5:DeferredTaxation2023-12-012024-11-3009231427ns5:DeferredTaxation2024-11-30
REGISTERED NUMBER: 09231427 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2024

FOR

EX PHARMACEUTICAL INSPECTORS CONSORTIUM
LIMITED

EX PHARMACEUTICAL INSPECTORS CONSORTIUM
LIMITED (REGISTERED NUMBER: 09231427)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 30 November 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


EX PHARMACEUTICAL INSPECTORS CONSORTIUM
LIMITED

COMPANY INFORMATION
for the Year Ended 30 November 2024







DIRECTORS: Mrs E A Allanson
D P Jones





REGISTERED OFFICE: 101 Galgate
Barnard Castle
Co. Durham
DL12 8ES





REGISTERED NUMBER: 09231427 (England and Wales)





ACCOUNTANTS: Blaeford Gordon & Company Ltd
101 Galgate
Barnard Castle
Co. Durham
DL12 8ES

EX PHARMACEUTICAL INSPECTORS CONSORTIUM
LIMITED (REGISTERED NUMBER: 09231427)

BALANCE SHEET
30 November 2024

30.11.24 30.11.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 42,810 51,056

CURRENT ASSETS
Debtors 5 291,046 294,534
Cash at bank 294,648 186,518
585,694 481,052
CREDITORS
Amounts falling due within one year 6 159,550 112,045
NET CURRENT ASSETS 426,144 369,007
TOTAL ASSETS LESS CURRENT
LIABILITIES

468,954

420,063

CREDITORS
Amounts falling due after more than one year 7 (3,267 ) (13,217 )

PROVISIONS FOR LIABILITIES 9 (10,702 ) (12,764 )
NET ASSETS 454,985 394,082

CAPITAL AND RESERVES
Called up share capital 900 900
Retained earnings 454,085 393,182
SHAREHOLDERS' FUNDS 454,985 394,082

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

EX PHARMACEUTICAL INSPECTORS CONSORTIUM
LIMITED (REGISTERED NUMBER: 09231427)

BALANCE SHEET - continued
30 November 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 6 January 2025 and were signed on its behalf by:




Mrs E A Allanson - Director



D P Jones - Director


EX PHARMACEUTICAL INSPECTORS CONSORTIUM
LIMITED (REGISTERED NUMBER: 09231427)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 30 November 2024

1. STATUTORY INFORMATION

Ex Pharmaceutical Inspectors Consortium Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Fixtures and fittings - 25% on reducing balance
Motor vehicles - 20% on reducing balance
Computer equipment - 25% on reducing balance

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 8 (2023 - 7 ) .

EX PHARMACEUTICAL INSPECTORS CONSORTIUM
LIMITED (REGISTERED NUMBER: 09231427)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 30 November 2024

4. TANGIBLE FIXED ASSETS
Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 December 2023 1,980 60,375 6,472 68,827
Additions - - 2,804 2,804
At 30 November 2024 1,980 60,375 9,276 71,631
DEPRECIATION
At 1 December 2023 1,782 12,075 3,914 17,771
Charge for year 50 9,660 1,340 11,050
At 30 November 2024 1,832 21,735 5,254 28,821
NET BOOK VALUE
At 30 November 2024 148 38,640 4,022 42,810
At 30 November 2023 198 48,300 2,558 51,056

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Motor
vehicles
£   
COST
At 1 December 2023
and 30 November 2024 60,375
DEPRECIATION
At 1 December 2023 12,075
Charge for year 9,660
At 30 November 2024 21,735
NET BOOK VALUE
At 30 November 2024 38,640
At 30 November 2023 48,300

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.24 30.11.23
£    £   
Trade debtors 275,603 294,534
VAT 15,443 -
291,046 294,534

EX PHARMACEUTICAL INSPECTORS CONSORTIUM
LIMITED (REGISTERED NUMBER: 09231427)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 30 November 2024

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.24 30.11.23
£    £   
Hire purchase contracts 9,925 9,925
Trade creditors 8,286 2,225
Tax 107,487 26,822
VAT - 41,731
Accrued expenses 33,852 31,342
159,550 112,045

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
30.11.24 30.11.23
£    £   
Hire purchase contracts 3,267 13,217

8. SECURED DEBTS

The following secured debts are included within creditors:

30.11.24 30.11.23
£    £   
Hire purchase contracts 13,192 23,142

Hire purchase creditors are secured by the asset to which they relate.

9. PROVISIONS FOR LIABILITIES
30.11.24 30.11.23
£    £   
Deferred tax 10,702 12,764

Deferred
tax
£   
Balance at 1 December 2023 12,764
Credit to Income Statement during year (2,062 )
Balance at 30 November 2024 10,702

10. ULTIMATE CONTROLLING PARTY

The controlling party is not known.

The ultimate controlling party is not known.